✦ LIBER ✦

Drug development and chemotherapy in acute lymphoblastic leukemia : Of mice to men

✍ Scribed by Gregory H. Reaman

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 89 KB
Volume: 83
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19981101)83:9<1885::aid-cncr1>3.0.co;2-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Growth and body composition in response

Growth and body composition in response to chemotherapy in children with acute lymphoblastic leukemia

✍ Jacqueline M. Halton,; Stephanie A. Atkinson; Ronald D. Barr 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 88 KB 👁 1 views

Severely malnourished children afflicted by acute lymphoblastic leukemia (ALL), particularly in developing countries, have reduced tolerance to chemotherapy and a compromised prospect for survival. We investigated the prevalence and severity of alterations in growth and nutritional status in childre

Dipyridamole enhancement of drug sensiti

Dipyridamole enhancement of drug sensitivity in acute lymphoblastic leukemia cells

✍ Dr. Manabu Sotomatsu; Shin-Ichirou Yugami; Toshiji Shitara; Takayoshi Kuroume 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB 👁 1 views

Urinary 6-hydroxymethylpterin levels acc

Urinary 6-hydroxymethylpterin levels accurately monitor response to chemotherapy in acute lymphoblastic leukemia

✍ K. Narasimha Rao; Sunil Trehan; P. A. Shetty; John M. Noronha 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB 👁 1 views

Bone and mineral abnormalities in childh

Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: Influence of disease, drugs and nutrition

✍ Stephanie A. Atkinson; Jacqueline M. Halton; Cristine Bradley; Binky Wu; Ronald 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 89 KB 👁 2 views

In children with acute lymphoblastic leukemia (ALL), abnormalities in mineral homeostasis and bone mass were first reported by our group in the late 1980s. Prospective longitudinal cohort studies in 40 consecutive patients receiving treatment according to the Dana-Farber Cancer Institute (DFCI) prot

Selective use of daunorubicin for remiss

Selective use of daunorubicin for remission-induction chemotherapy in acute non-lymphoblastic leukemia

✍ B. S. Shaikh; J. B. Dougherty; R. W. Hamilton; J. O. Ballard; S. B. Patel; N. R. 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB 👁 2 views

Twenty-eight patients with acute non-lymphoblastic leukemia (ANLL) were started on induction chemotherapy consisting of Cytosine Arbinoside (Ara C) and 6 thioguanine (TG). Daunoruhicin (DNR) was used selectively in 20 of 28 patients who failed to respond by day 14 to the Ara C and TG combination. Se

Acute lymphoblastic leukemia in children

Acute lymphoblastic leukemia in children: Nonrandomized comparison of conventional vs. intensive chemotherapy at the National Cancer Institute of Colombia

✍ Buendia, Maria Teresa Amparo; Terselich, Greti; Lozano, Juan Manuel; Viscaino, M 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

## Background: This study aimed to compare the therapeutic efficacy of two treatments for childhood acute lymphoblastic leukemia (all), and to evaluate the feasibility of intensive chemotherapy in a developing country. ## Methods: The study was conducted at the national cancer institute in bogota